This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Dr. Soliman Fakeeh Hospital, Erasmus University Medical Center. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020
Title: Ali Moh Zaki: Innovator in Viral Research
Introduction
Ali Moh Zaki is a prominent inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of virology, particularly in understanding human coronaviruses. His work has implications for diagnostics, prevention, and treatment of respiratory diseases in humans.
Latest Patents
Ali Moh Zaki holds a patent titled "Human Betacoronavirus lineage C and identification of N-terminal dipeptidyl peptidase as its virus receptor." This invention provides an isolated essentially mammalian positive-sense single-stranded RNA virus that is classifiable within the Order: Nidovirales; Family: Coronaviridae; Subfamily: Coronavirinae. The invention also identifies a human virus with a receptor binding domain capable of binding to dipeptidyl peptidase 4. Furthermore, it offers diagnostic means and methods, prophylactic means and methods, and therapeutic means and methods for the diagnosis, prevention, and treatment of respiratory diseases, particularly in humans.
Career Highlights
Throughout his career, Ali Moh Zaki has worked with esteemed institutions such as Erasmus University Medical Center Rotterdam and Dr. Soliman Fakeeh Hospital. His research has been pivotal in advancing our understanding of viral infections and their impact on human health.
Collaborations
Ali Moh Zaki has collaborated with notable colleagues, including Bartholomeus Leonardus Haagmans and Theodorus Marinus Bestebroer. Their joint efforts have contributed to significant advancements in the field of virology.
Conclusion
Ali Moh Zaki's innovative work in viral research has led to important discoveries that enhance our understanding of coronaviruses and their treatment. His contributions are vital in the ongoing fight against respiratory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile